Lung cancer patients have been associated with an increased risk of COVID-19 infection,
pulmonary complications, and worse survival outcomes compared to the general population …

Cancer patients are highly vulnerable to SARS-CoV-2 infections due to frequent contacts
with the healthcare system, immunocompromised state from cancer or its therapies …

Abstract Purpose of Review Since the past year, the fast spread of coronavirus disease 2019
(COVID-19) has represented a global health threat, especially for cancer patients, that has …

Simple Summary COVID-19 is a respiratory infectious disease caused by the coronavirus
SARS-CoV-2. Lung cancer is the leading cause of all cancer-related deaths worldwide. As …

Lung cancer, considered one of the most common causes of cancer deaths worldwide, is a
complex disease with its own challenges. The coronavirus disease 2019 (COVID-19) …

Patients with lung cancer are especially vulnerable to coronavirus disease 2019 (COVID-19)
with a greater than sevenfold higher rate of becoming infected with severe acute respiratory …

Background Patients with lung cancers may have disproportionately severe coronavirus
disease 2019 (COVID-19) outcomes. Understanding the patient-specific and cancer-specific …

Abstract Treatment of patients with lung cancer during the current COVID-19 pandemic is
challenging. Lung cancer is a heterogenous disease with a wide variety of therapeutic …

Simple Summary The coronavirus disease (COVID-19) pandemic has increased morbidity
and mortality in the general population. Patients with cancer have immune dysfunction due …

Oncology patients are more susceptible to severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) infection due to hospital contact and an immunological system that can be …